Changes in Radiosensitivity to Gamma-Rays of Lymphocytes from Hyperthyroid Patients Treated with I-131.
H2AX histone phosphorylation
I-131 therapy
micronucleus tests
peripheral blood lymphocytes
radio-sensitivity
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
05 Sep 2022
05 Sep 2022
Historique:
received:
18
07
2022
revised:
17
08
2022
accepted:
27
08
2022
entrez:
9
9
2022
pubmed:
10
9
2022
medline:
14
9
2022
Statut:
epublish
Résumé
This study investigated the peripheral blood lymphocytes (PBL) response to a dose of γ-rays in patients treated with radioiodine (I-131) for hyperthyroidism vs. healthy controls, to gain information about the individual lymphocytes' radio-sensitivity. Blood samples were taken from 18 patients and 10 healthy donors. Phosphorylated histone variant H2AX (γ-H2AX) and micronuclei (MN) induction were used to determine the change in PBL radio-sensitivity and the correlations between the two types of damage. The two assays showed large inter-individual variability in PBL background damage and in radio-sensitivity (patients vs. healthy donors). In particular, they showed an increased radio-sensitivity in 36% and 33% of patients, decrease in 36% and 44%, respectively. There was a scarce correlation between the two assays and no dependence on age or gender. A significant association was found between high radio-sensitivity conditions and induced hypothyroidism. PBL radio-sensitivity in the patient group was not significantly affected by treatment with I-131, whereas there were significant changes inter-individually. The association found between clinical response and PBL radio-sensitivity suggests that the latter could be used in view of the development of personalized treatments.
Identifiants
pubmed: 36077557
pii: ijms231710156
doi: 10.3390/ijms231710156
pmc: PMC9456272
pii:
doi:
Substances chimiques
Iodine Radioisotopes
0
Iodine-131
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Mutagenesis. 2017 Mar 1;32(2):267-273
pubmed: 27831478
Eur Heart J. 2012 Feb;33(3):408-14
pubmed: 21862464
J Nucl Med. 2016 Feb;57(2):173-9
pubmed: 26564321
N Engl J Med. 2011 Feb 10;364(6):542-50
pubmed: 21306240
Mutat Res. 2013 Apr-Jun;752(2):84-98
pubmed: 23262375
J Nucl Med. 2015 Apr;56(4):505-11
pubmed: 25722453
PLoS One. 2011;6(9):e25113
pubmed: 21966430
Mutat Res. 2012 Oct-Dec;751(2):258-286
pubmed: 22677531
Mutagenesis. 2011 Jan;26(1):111-7
pubmed: 21164191
Leukemia. 2010 Apr;24(4):679-86
pubmed: 20130602
Environ Mol Mutagen. 2007 Jan;48(1):38-47
pubmed: 17163504
Nat Rev Cancer. 2008 Dec;8(12):957-67
pubmed: 19005492
Health Phys. 1991 Nov;61(5):623-30
pubmed: 1752745
Mutat Res. 2000 Nov 20;455(1-2):81-95
pubmed: 11113469
Eur J Nucl Med Mol Imaging. 2010 Nov;37(11):2218-28
pubmed: 20625722
Genome Integr. 2018 May 31;9:2
pubmed: 30820313
Endocrinol Metab (Seoul). 2016 Mar;31(1):168-73
pubmed: 26996425
Radiat Environ Biophys. 2015 May;54(2):183-94
pubmed: 25636513
Thyroid. 2011 Jun;21(6):593-646
pubmed: 21510801
Radiat Res. 2011 Aug;176(2):139-57
pubmed: 21631286
Adv Space Res. 2003;31(6):1543-51
pubmed: 12971409
Eur J Endocrinol. 2009 Nov;161(5):771-7
pubmed: 19671708
Nuklearmedizin. 2011;50(3):93-9; quiz N20
pubmed: 21165539
Int J Radiat Biol. 2018 Jan;94(1):54-61
pubmed: 29095072
Eur J Nucl Med Mol Imaging. 2012 Nov;39(11):1712-9
pubmed: 22854986
Cancer Lett. 2012 Dec 31;327(1-2):123-33
pubmed: 22198208
Mutagenesis. 2011 Jan;26(1):101-6
pubmed: 21164189
Mutat Res Genet Toxicol Environ Mutagen. 2019 Feb;838:59-66
pubmed: 30678829
Dose Response. 2015 Nov 19;13(4):1559325815611904
pubmed: 26740810
Indian J Endocrinol Metab. 2014 Sep;18(5):648-54
pubmed: 25285281
Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1126-34
pubmed: 23576099
J Nucl Med. 2010 Aug;51(8):1318-25
pubmed: 20660387
Mutagenesis. 2011 Jan;26(1):11-7
pubmed: 21164177
Nucleic Acids Res. 2007;35(5):e36
pubmed: 17284459
J Biol Chem. 1998 Mar 6;273(10):5858-68
pubmed: 9488723
J Nucl Med. 2000 Jan;41(1):17-22
pubmed: 10647600